Codexis (CDXS) EBITDA Margin Growth (3y) (2013 - 2026)
Codexis (CDXS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Codexis |
236.00 Mn |
170.86 Mn |
13.18 Mn |
12,954.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
12,954.00 |
| Dec 31, 2025 |
9,405.00 |
| Sep 30, 2025 |
-18,946.00 |
| Jun 30, 2025 |
-7,712.00 |
| Mar 31, 2025 |
-24,786.00 |
| Dec 31, 2024 |
818.00 |
| Sep 30, 2024 |
-13,264.00 |
| Jun 30, 2024 |
-26,727.00 |
| Mar 31, 2024 |
-1,886.00 |
| Dec 31, 2023 |
2,428.00 |
| Sep 30, 2023 |
-31,260.00 |
| Jun 30, 2023 |
-21,172.00 |
| Mar 31, 2023 |
-12,894.00 |
| Dec 31, 2022 |
-6,184.00 |
| Sep 30, 2022 |
-3,204.00 |
| Jun 30, 2022 |
4,697.00 |
| Mar 31, 2022 |
989.00 |
| Dec 31, 2021 |
-3,838.00 |
| Sep 30, 2021 |
1,604.00 |
| Jun 30, 2021 |
1,073.00 |
